Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1967 1
1979 1
1980 1
1981 1
1984 2
1985 2
1986 2
1987 4
1988 4
1989 2
1990 3
1991 1
1993 1
1994 2
1995 2
1996 2
1997 3
1999 1
2000 1
2001 6
2002 4
2003 4
2004 11
2005 6
2006 6
2007 13
2008 10
2009 28
2010 23
2011 13
2012 5
2013 11
2014 10
2015 9
2016 18
2017 10
2018 22
2019 17
2020 17
2021 14
2022 19
2023 21
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Results by year

Filters applied: . Clear all
Page 1
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
Lee CH, Voss MH, Carlo MI, Chen YB, Zucker M, Knezevic A, Lefkowitz RA, Shapnik N, Dadoun C, Reznik E, Shah NJ, Owens CN, McHugh DJ, Aggen DH, Laccetti AL, Kotecha R, Feldman DR, Motzer RJ. Lee CH, et al. Among authors: knezevic a. J Clin Oncol. 2022 Jul 20;40(21):2333-2341. doi: 10.1200/JCO.21.01944. Epub 2022 Mar 17. J Clin Oncol. 2022. PMID: 35298296 Free PMC article. Clinical Trial.
JUVENILE POLYP IN ADULTS.
Popović M, Knežević A, Dolinaj Škopelja J, Đolai M. Popović M, et al. Among authors: knezevic a. Acta Clin Croat. 2022 Aug;61(2):354-358. doi: 10.20471/acc.2022.61.02.23. Acta Clin Croat. 2022. PMID: 36818922 Free PMC article.
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma.
Erazo T, Evans CM, Zakheim D, Chu KL, Refermat AY, Asgari Z, Yang X, Da Silva Ferreira M, Mehta S, Russo MV, Knezevic A, Zhang XP, Chen Z, Fennell M, Garippa R, Seshan V, de Stanchina E, Barbash O, Batlevi CL, Leslie CS, Melnick AM, Younes A, Kharas MG. Erazo T, et al. Among authors: knezevic a. Nat Commun. 2022 Sep 27;13(1):5676. doi: 10.1038/s41467-022-33137-8. Nat Commun. 2022. PMID: 36167829 Free PMC article.
Antioxidant protective effects of mushroom metabolites.
Stajić M, Vukojević J, Knežević A, Laušević SD, Milovanović I. Stajić M, et al. Among authors: knezevic a. Curr Top Med Chem. 2013;13(21):2660-76. doi: 10.2174/15680266113136660192. Curr Top Med Chem. 2013. PMID: 24083793 Review.
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer.
Kotecha RR, Doshi SD, Knezevic A, Chaim J, Chen Y, Jacobi R, Zucker M, Reznik E, McHugh D, Shah NJ, Feld E, Aggen DH, Rafelson W, Xiao H, Carlo MI, Feldman DR, Lee CH, Motzer RJ, Voss MH. Kotecha RR, et al. Among authors: knezevic a. Eur Urol Oncol. 2023 Nov 7:S2588-9311(23)00229-8. doi: 10.1016/j.euo.2023.10.017. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37945488
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
Kotecha RR, Knezevic A, Arora K, Bandlamudi C, Kuo F, Carlo MI, Fitzgerald KN, Feldman DR, Shah NJ, Reznik E, Hakimi AA, Carrot-Zhang J, Mandelker D, Berger M, Lee CH, Motzer RJ, Voss MH. Kotecha RR, et al. Among authors: knezevic a. Cancer. 2024 Mar 1;130(5):692-701. doi: 10.1002/cncr.35074. Epub 2023 Oct 21. Cancer. 2024. PMID: 37864521
323 results